- Understand current approaches to treating and managing cardiovascular patients for long-term health, for complex problems, and for unusual cardiac events.
- Benefit from the substantial experience of Elliott M. Antman, MD, Marc S. Sabatine, MD, and a host of other respected authorities, who provide practical, evidence-based rationales for all of today's clinical therapies.
- Expand your knowledge beyond pharmacologic interventions with complete coverage of the most effective interventional and device therapies being used today.
- Easily reference Braunwald's Heart Disease, 9th Edition for further information on topics of interest.
PART I DECISION MAKING AND THERAPEUTIC STRATEGIES IN CARDIOVASCULAR
Chapter 1 Tools for Assessment of Cardiovascular Tests and Therapies
Chapter 2 New Drug Development
Chapter 3 Device Development for Cardiovascular Therapeutics: Concepts and Regulatory Implications
Chapter 4 Pharmacogenetics
Chapter 5 Systems of Health Care
Chapter 6 Global Cardiovascular Therapy
PART II ISCHEMIC HEART DISEASE
Chapter 7 Pharmacologic Options for Treatment of Ischemic Disease
Chapter 8 Stable Ischemic Heart Disease/Chronic Stable Angina
Chapter 9 Non–ST-Segment Elevation Acute Coronary Syndromes
Chapter 10 ST-Segment Elevation Myocardial Infarction
Chapter 11 Advances in Coronary Revascularization
PART III HEART FAILURE
Chapter 12 Pharmacologic Management of Heart Failure in the Ambulatory Setting
Chapter 13 Implantable Devices for the Management of Heart Failure
Chapter 14 Strategies for Management of Acute Decompensated Heart Failure
Chapter 15 Cardiac Transplantation and Circulatory Support Devices
Chapter 16 Regenerative Therapy for Heart Failure
Chapter 17 Hypertrophic, Restrictive, and Infiltrative Cardiomyopathies
PART IV ARRHYTHMIAS AND CONDUCTION DISTURBANCES
Chapter 18 Clinical Pharmacology of Antiarrhythmic Drugs
Chapter 19 Pharmacologic Management of Supraventricular Tachycardias
Chapter 20 Atrial Fibrillation
Chapter 21 Nonpharmacologic Treatment of Tachyarrhythmias
Chapter 22 Role of Implantable Cardioverter-Defibrillators in Primary and Secondary Prevention of Sudden Cardiac Death
Chapter 23 Treatment of Ventricular Tachycardia and Cardiac Arrest
PART V DYSLIPOPROTEINEMIAS AND ATHEROSCLEROSIS
Chapter 24 Drugs for Elevated Low-Density Lipoprotein